News

Highest excess risk for mortality, CV mortality, heart failure, CHD seen for T2DM patients diagnosed before 40

Unauthorized, preowned test strips could cause infection, inaccuracy

Dose-response relationship observed in large European cohort

Mental health issues consistent across BMI groups; social, mechanical issues more common with higher BMI

Findings remain significant even when accounting for years in practice and type of practice

Obstructive sleep apnea, but not SSD, is linked to obesity, hypertension, and dyslipidemia

Early identification and management decreases hyperglycemia, hospital-acquired infections

Rising costs of insulin causing patients to ration their doses or even do without the drug

Genetic evidence shows elevated SHBG levels may protect against asthma, mostly in females

Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for March 2019. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.Shorter Reproductive …